Haemorrhagic and haematological disorders of fetus and newborn

P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 P50-P61
Cause of death: ICD-10 P50-P61

357

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

357

diagram downward connector

Check minimum number of events None

357

diagram downward connector
P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF4
Parent code in ICD-10 P
Name in latin Morbositates haemorrhagicae et haematologicae fetus et neonati

Similar endpoints

List of similar endpoints to Haemorrhagic and haematological disorders of fetus and newborn based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 330 165 165
Unadjusted prevalence (%) 0.11 0.10 0.12
Mean age at first event (years) 0.52 0.48 0.55

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO – Haemorrhagic and haematological disorders of fetus and newborn
GWS hits: 0

Survival analyses between endpoints

Plot

before Haemorrhagic and haematological disorders of fetus and newborn
after Haemorrhagic and haematological disorders of fetus and newborn

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Haemorrhagic and haematological disorders of fetus and newborn